1. Patient Reported Endpoints for Measuring Clinical Benefit in (High Grade Glioma) Primary Brain Tumor Patients

   • Terri S. Armstrong
   • Mark R. Gilbert

   Neuro-oncology (GJ Lesser, Section Editor) 31 August 2014 Pages: 519 - 528

   

2. Therapeutic Decision Making in Patients with Newly Diagnosed Low Grade Glioma

   • Adesh Tandon
   • David Schiff

   Neuro-oncology (GJ Lesser, Section Editor) 20 August 2014 Pages: 529 - 538

   

3. Treatment of Radiation-Induced Cognitive Decline

   • Albert Attia
   • Brandi R. Page
   • Michael Chan

   Neuro-oncology (GJ Lesser, Section Editor) 17 September 2014 Pages: 539 - 550

4. Current Role of Anti-Angiogenic Strategies for Glioblastoma

   • Alissa A. Thomas
   • Antonio Omuro

   Neuro-oncology (GJ Lesser, Section Editor) 31 August 2014 Pages: 551 - 566

   

5. Therapeutic Strategies for Cancer Treatment Related Peripheral Neuropathies

   • Deirdre R. Pachman
   • James C. Watson
   • Charles L. Loprinzi

   Neuro-oncology (GJ Lesser, Section Editor) 14 August 2014 Pages: 567 - 580

6. Management of Pediatric and Adult Patients with Medulloblastoma

   • Allison M. Martin
   • Eric Raabe
   • Kenneth J. Cohen

   Neuro-oncology (GJ Lesser, Section Editor) 07 September 2014 Pages: 581 - 594

   

7. Human Papillomavirus-Associated Oropharynx Cancer (HPV-OPC): Treatment Options

   • Nicole G. Chau
   • Guilherme Rabinowits
   • Robert I. Haddad

   Head and Neck Cancer (J-P Machiels, Section Editor) 21 September 2014 Pages: 595 - 610

   

8. The Role of Neck Dissection in Squamous Cell Carcinoma of the Head and Neck

   • Marc Hamoir
   • Sandra Schmitz
   • Vincent Gregoire

   Head and Neck Cancer (J-P Machiels, Section Editor) 17 September 2014 Pages: 611 - 624

9. Interventional Pulmonologist Perspective: Treatment of Malignant Pleural Effusion

   • Andrew J. Sweatt
   • Arthur Sung

   Head and Neck Cancer (J-P Machiels, Section Editor) 21 September 2014 Pages: 625 - 643

   

10. The Minority Report: Targeting the Rare Oncogenes in NSCLC

    • Caroline E. McCoach
    • Robert C. Doebele

    Lung Cancer (HA Wakelee, Section Editor) 18 September 2014 Pages: 644 - 657

11. Immune Checkpoint Inhibitors in NSCLC

    • Douglas B. Johnson
    • Matthew J. Rioth
    • Leora Horn

    Lung Cancer (HA Wakelee, Section Editor) 06 August 2014 Pages: 658 - 669

12. c-MET Inhibitors in the Treatment of Lung Cancer

    • Joanna Goździk-Spychalska
    • Katarzyna Szyszka-Barth
    • Rodryg Ramlau

    Lung Cancer (HA Wakelee, Section Editor) 30 September 2014 Pages: 670 - 682

13. Local and Systemic Therapies for Malignant Pleural Mesothelioma

    • Daniel Gomez
    • Anne S. Tsao

    Lung Cancer (HA Wakelee, Section Editor) 30 September 2014 Pages: 683 - 699